XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Revenue Recognition, Accounts Receivable and COVID-19 (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended 33 Months Ended
Dec. 14, 2022
Jan. 04, 2022
Apr. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2022
Revenue Recognition              
Net revenue       $ 2,970,595 $ 2,454,535 $ 1,056,389  
Unbilled revenue       38,600 23,800   $ 38,600
CARES Act funding received     $ 17,200        
CARES Act income recognized       0 10,595 14,277  
Recoupable advance payment under CARES Act     45,800        
CARES Act funding recouped       12,800 36,700    
Employment taxes deferred, CARES Act             $ 8,600
Payment of deferred employment tax $ 4,300 $ 4,300          
Significant Acquisitions In 2020              
Revenue Recognition              
CARES Act funding received     22,200        
Business combination, liabilities     7,700        
Business combination, recoupable advances     $ 3,700        
Transferred at Point in Time              
Revenue Recognition              
Net revenue       2,015,680 1,639,406 759,297  
Transferred over Time              
Revenue Recognition              
Net revenue       954,915 815,129 297,092  
Sleep              
Revenue Recognition              
Net revenue       1,066,726 891,382 411,221  
Sleep | Transferred at Point in Time              
Revenue Recognition              
Net revenue       794,021 654,130 312,860  
Sleep | Transferred over Time              
Revenue Recognition              
Net revenue       272,705 237,252 98,361  
Diabetes              
Revenue Recognition              
Net revenue       687,091 541,205 161,957  
Diabetes | Transferred at Point in Time              
Revenue Recognition              
Net revenue       670,988 528,082 159,490  
Diabetes | Transferred over Time              
Revenue Recognition              
Net revenue       16,103 13,123 2,467  
Supplies to the home              
Revenue Recognition              
Net revenue       179,326 167,830 145,624  
Supplies to the home | Transferred at Point in Time              
Revenue Recognition              
Net revenue       179,326 167,830 145,624  
Respiratory              
Revenue Recognition              
Net revenue       555,039 458,286 152,465  
Respiratory | Transferred at Point in Time              
Revenue Recognition              
Net revenue       34,342 31,016 28,605  
Respiratory | Transferred over Time              
Revenue Recognition              
Net revenue       520,697 427,270 123,860  
HME              
Revenue Recognition              
Net revenue       220,798 209,741 113,876  
HME | Transferred at Point in Time              
Revenue Recognition              
Net revenue       118,542 113,805 58,029  
HME | Transferred over Time              
Revenue Recognition              
Net revenue       102,256 95,936 55,847  
Other              
Revenue Recognition              
Net revenue       261,615 186,091 71,246  
Other | Transferred at Point in Time              
Revenue Recognition              
Net revenue       218,461 144,543 54,689  
Other | Transferred over Time              
Revenue Recognition              
Net revenue       43,154 41,548 16,557  
Insurance              
Revenue Recognition              
Net revenue       1,808,633 1,499,154 657,033  
Government              
Revenue Recognition              
Net revenue       781,975 685,513 295,657  
Patient pay              
Revenue Recognition              
Net revenue       $ 379,987 $ 269,868 $ 103,699